Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early switch to romiplostim in steroid-unresponsive newly diagnosed ITP
ChiCTR2500104776Phase 2Not yet recruiting
- Sponsor
- Huai'an First People's Hospital
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in immune thrombocytopenia (ITP), sponsored by Huai'an First People's Hospital. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2500104776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104776.